Skip to main content
logo
Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,255.40
+11.00 (0.88%)
At close: Aug 21, 2026, 4:00 PM EDT
1,257.01
+1.61 (0.13%)
Pre-market: Aug 24, 2026, 4:09 AM EDT

Eli Lilly Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
22,97419,79919,29217,60115,55812,72913,53311,43911,3038,7689,3539,4998,3126,9607,3026,9426,4887,8108,0006,773
Revenue Growth
47.67%55.54%42.55%53.86%37.65%45.18%44.69%20.43%35.98%25.98%28.10%36.84%28.12%-10.88%-8.73%2.49%-3.74%14.76%7.53%17.98%
Gross Profit
19,70616,22215,92014,59313,11010,50411,1309,2689,1337,0957,5657,6396,5055,3335,7545,3635,0585,7385,8545,342
Operating Income
12,4579,7788,6618,5007,0215,3025,3364,5504,4192,7363,1933,5412,3381,7152,2082,0381,7452,6632,4372,131
Net Income
7,0957,3966,6385,5835,6612,7594,410970.32,9672,2432,190-57.41,7631,3451,9381,452952.51,9031,7261,110
Earnings Per Share
7.948.267.396.216.293.064.881.073.282.482.42-0.061.951.492.141.611.052.101.891.22
EPS Growth
26.23%169.94%51.39%480.37%91.77%23.39%101.86%-68.20%66.44%13.01%-85.71%-29.05%12.99%31.97%-31.37%40.94%-18.33%-8.27%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Basaglar
143206145162.2145173.6176.9161.6180.8157.6185.2179.6154.2209.3201.7193174.2191.5242.4192.8
Foundayo
98-------------------
Humalog
410442529599.1503.1537.2619.9534.6631.6538.7366.6395.4440.4460.9548.3447447.1618.2601.7626.7
Humulin
153160180176.6175.2173.2280.3207.1223.6206.2188.1206.7205.3252234238.2274273.2298.8286.7
Jardiance
1,2321,1147689596901,0141,198686.4769.6686.5798.1700.8668.3577.5612.3573.3461419.4431.9390.4
Mounjaro
9,9438,6627,4096,5155,1993,8423,5303,1133,0911,8072,2061,409979.7568.5279.2187.316---
Trajenta
73767971.391.876.396.691.776.688.9102.295.2103.685.890.8103.897.19292.696.1
Trulicity
1,2199191,0371,0521,0921,0951,2501,3011,2461,4561,6691,6741,8131,9771,9361,8501,9121,7411,8841,600
Zepbound
4,9284,1604,2613,5883,3812,3121,9071,2581,243517.4175.8---------
Other Cardiometabolic Health
154228454.565.4-15.746.653.752.934.935.946.732.727.827.916.520.116.336.639
Oncology
2,5702,2682,6072,4082,4141,9482,5522,2322,1591,8101,8841,7471,6711,3561,6511,2931,3691,3531,4091,406
Immunology
1,4171,2031,5411,3621,2561,0881,2911,1861,0828341,104986.9928.5777.8933.6866.4796.5748.1956.61,005
Neuroscience
429382460315.7344272.1393.1351.8339.5389.1362.81,768387.2360.5385.3373.2390397.7470.6450.1
Other Product
205187192337.2201.5212.9190.6262.8207.6241.9256.2276.1314.6275.3355.9746494.81,9231,536637.6
Revenue (Total)
22,97419,79919,29217,60115,55812,72913,53311,43911,3038,7689,3539,4998,3126,9607,3026,9426,4887,8108,0006,773

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
9,7465,7307,49110,2333,9663,6843,7544,0713,8393,3533,7533,1563,5194,3493,1263,3733,3813,3805,1935,335
Total Debt
54,90843,37043,86542,57839,98138,60434,79131,23129,02826,34726,46520,33218,95418,98516,37316,04216,90416,55216,92717,137
Net Cash (Debt)
-45,162-37,640-36,374-32,344-36,015-34,921-31,037-27,160-25,189-22,994-22,712-17,176-15,435-14,636-13,247-12,669-13,523-13,173-11,733-11,802
Net Cash Growth
--------------------
Net Cash Per Share
-50.53-42.01-40.51-35.99-40.03-38.78-34.36-30.01-27.86-25.44-25.12-19.09-17.10-16.20-14.64-14.02-14.98-14.53-12.90-12.96

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
10,6905,3333,2258,8363,0871,6662,4743,7121,4661,166-311.92,190631.91,7311,6632,2171,1832,5232,1571,631
Capital Expenditures
-2,933-2,326-2,547-2,088-1,697-1,510-1,496-1,351-1,225-986.3-1,071-970.3-738.2-668.5-500.7-617.2-371-365.4-291.4-336.8
Free Cash Flow
7,7573,007677.96,7481,390156977.72,361241.4179.7-1,3831,219-106.31,0621,1621,600812.32,1581,8651,295
Free Cash Flow Growth
458.06%1827.56%-30.66%185.79%475.81%-13.19%-93.67%--83.08%--23.78%--50.77%-37.70%23.56%-41.74%54.43%37.09%-8.42%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
85.78%81.93%82.52%82.91%84.27%82.52%82.24%81.02%80.80%80.91%80.88%80.42%78.26%76.63%78.80%77.25%77.95%73.47%73.18%78.87%
Operating Margin
54.22%49.39%44.90%48.29%45.13%41.65%39.43%39.77%39.09%31.20%34.14%37.28%28.13%24.64%30.23%29.36%26.89%34.10%30.46%31.47%
Pretax Margin
40.25%44.70%42.85%41.09%43.56%27.15%37.23%13.89%31.12%28.92%26.82%4.50%25.13%21.98%28.71%22.55%16.81%26.29%23.00%18.39%
Profit Margin
30.88%37.35%34.41%31.72%36.39%21.68%32.58%8.48%26.25%25.58%23.41%-0.60%21.21%19.32%26.54%20.91%14.68%24.37%21.58%16.39%
FCF Margin
33.76%15.19%3.51%38.34%8.93%1.23%7.22%20.64%2.14%2.05%-14.78%12.84%-1.28%15.26%15.91%23.04%12.52%27.63%23.31%19.11%

Dividends
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Dividend Per Share
1.7301.7301.5001.5001.5001.5001.3001.3001.3001.3001.1301.1301.1301.1300.9800.9800.9800.9800.8500.850
Dividend Per Share Growth
15.33%15.33%15.38%15.38%15.38%15.38%15.04%15.04%15.04%15.04%15.31%15.31%15.31%15.31%15.29%15.29%15.29%15.29%14.87%14.87%
Dividend Yield
0.54%0.68%0.56%0.77%0.73%0.66%0.68%0.58%0.55%0.61%0.79%0.83%0.92%1.22%1.10%1.21%1.17%1.28%1.28%1.49%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
40.0432.5646.6237.2050.7166.7865.6495.31111.03114.16100.04-68.5254.4755.6650.9351.2842.1644.8635.07
Forward PE
32.1526.5134.3327.4931.2135.5535.1342.9661.5462.3953.3747.5151.1040.5146.2740.1242.6833.0931.7728.80
P/FCF Ratio
58.8069.61107.2573.88143.26198.50184.88569.883162.18--144.75-66.8160.6547.7547.6238.5042.0838.46
PS Ratio
13.4311.3914.7611.5313.1415.1415.4319.5220.9419.5015.3615.0615.0811.1912.1810.5110.048.818.847.55